HomeCompareGLYYY vs MRK

GLYYY vs MRK: Dividend Comparison 2026

GLYYY yields 1.43% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLYYY wins by $1.77M in total portfolio value· pulled ahead in Year 4
10 years
GLYYY
GLYYY
● Live price
1.43%
Share price
$21.47
Annual div
$0.31
5Y div CAGR
84.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.83M
Annual income
$1,400,419.15
Full GLYYY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLYYY vs MRK

📍 GLYYY pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLYYYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLYYY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLYYY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLYYY
Annual income on $10K today (after 15% tax)
$121.45/yr
After 10yr DRIP, annual income (after tax)
$1,190,356.28/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GLYYY beats the other by $1,182,027.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLYYY + MRK for your $10,000?

GLYYY: 50%MRK: 50%
100% MRK50/50100% GLYYY
Portfolio after 10yr
$941.8K
Annual income
$705,108.65/yr
Blended yield
74.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLYYY
No analyst data
Altman Z
2.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLYYY buys
0
MRK buys
0
No recent congressional trades found for GLYYY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLYYYMRK
Forward yield1.43%2.76%
Annual dividend / share$0.31$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR84.3%32.7%
Portfolio after 10y$1.83M$56.8K
Annual income after 10y$1,400,419.15$9,798.13
Total dividends collected$1.77M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GLYYY vs MRK ($10,000, DRIP)

YearGLYYY PortfolioGLYYY Income/yrMRK PortfolioMRK Income/yrGap
1$10,963$263.32$11,206$366.19$243.00MRK
2$12,228$497.25$12,650$502.35$422.00MRK
3$14,039$955.28$14,407$694.19$368.00MRK
4← crossover$16,911$1,889.12$16,585$967.82+$326.00GLYYY
5$22,014$3,919.50$19,342$1,363.89+$2.7KGLYYY
6$32,344$8,788.34$22,913$1,947.19+$9.4KGLYYY
7$56,848$22,239.84$27,662$2,823.89+$29.2KGLYYY
8$128,155$67,327.95$34,159$4,173.35+$94.0KGLYYY
9$398,558$261,432.65$43,337$6,308.80+$355.2KGLYYY
10$1,826,877$1,400,419.15$56,776$9,798.13+$1.77MGLYYY

GLYYY vs MRK: Complete Analysis 2026

GLYYYStock

Glory Ltd. develops and manufactures cash handling machines and systems. It operates through Financial Market, Retail and Transportation Market, Amusement Market, and Overseas Market segments. The company provides teller cash recyclers, bank note counters, bank sorters, coin dispensers, coin sorters, coin counters, coin wrappers, and rolled coin dispensers, as well as self service solutions, bank note deposit solutions, and assisted service software solutions; cash recycling systems, front office-cash recyclers, banknote recyclers, payment station, and coin deposit solutions; remote customer displays; UW-F series; WR-90/500; and OEM cash dispensing systems, OEM cash deposit machines, and OEM cash recycling systems. The company also offers software solutions, such as business intelligence, device management, resource planning, retail cash management, serial number management, teller connectivity, and managed services. In addition, it offers professional, maintenance, and Ubiqular manage treasury managed services. Further, the company offers open teller systems, card systems, pachinko prize dispensing machines, and ticket vending machines, as well as self-service kiosks, mail ordering systems, and digital menu boards. It serves the CIT, financial, gaming, OEM, restaurant, amusement, and retail industries. The company was formerly known as Kokuei Machinery Manufacturing Co., Ltd. and changed its name to Glory Ltd. in 1971. The company was founded in 1918 and is headquartered in Himeji, Japan.

Full GLYYY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLYYY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLYYY vs SCHDGLYYY vs JEPIGLYYY vs OGLYYY vs KOGLYYY vs MAINGLYYY vs JNJGLYYY vs ABBVGLYYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.